Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
The Economic Burden of Liver Transplantation fo...
By
Melike Belenli Gümüş
July 23, 2024
Introduction Hepatitis B virus (HBV) infection poses a substantial global challenge, ...
Access to Essential Medicines for Rheumatic Diseases in Children
Biosimilars in Juvenile Arthritis Management: Connecting the Treatment Continuum
The Role of Pull Incentives in Addressing Antimicrobial Resistance
Cost-Utility and Cost-Effectiveness of Disease-Modifying Drugs for Relapsing-...
The Shift to Value-Based Drug Pricing in the United States
Unlocking the Potential of Cell and Gene Therapies: A Path to Affordable Heal...
Strategies for Fair Drug Pricing: Balancing Pharmacy Viability and Cost Conta...
Sustainable Pricing in Diabetes: Cost-Effective Medication Access
Biosimilar Competition and Patient Out-of-Pocket Costs
Managing Access to Medicines in the Future: Innovations and Strategies
Economics in Clinical Trials: A Guide to Value-Based Decisions
Policy of Innovative Health Technology: Biobanks in Abu Dhabi
« Previous
1
…
4
5
6
7
8
9
Next »